Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Prediction of second-line therapy response in metastatic renal cell carcinoma patients by blood plasma marker proteins.

Hölters, S., Bergmann, L., Grünwald, V., Keilholz, U., Ohlmann, C., Staehler, M., Schmerler, D., Junker, K., 2013.

Meeting of the EAU Section of Urological Research P17.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: ESUR (EAU) / Journal: -
MARC-2
2013
Bone metastasis in solid tumors in German outpatient centers – data from clinical registries.

Hartmann, H., Fietz, T., Köhler, A., Marschner, N., 2013.

Onkologie 36 (suppl. 7)(P842), 258. doi:10.1159/000356365

Abstract

Download

Indikation: Other, Sonstige / Veranstaltung: DGHO / Journal: Onkologie
Registerübergreifend
2013
Efficacy of trastuzumab re-therapy in routine treatment of HER2-positive breast cancer patients who relapsed after completed (neo-)adjuvant anti-HER2 therapy.

Hanker, L., Hitschold, T., Hesse, T., Grafe, A., Förster, F., Schröder, J., Janssen, J., Reichert, D., Hielscher, C., Greinemann, J., Bórquez, D., Schmidt, M., 2013.

J Clin Oncol 31(suppl; abstr 602). doi:DOI: 10.1200/jco.2013.31.15_suppl.602

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
Herceptin-NIS
2013
Effectiveness of sequential treatment of advanced or metastatic renal cell carcinoma (mRCC). Outcome data from the clinical RCC Registry.

Goebell, P.J., Müller, L., Lück, A., Overkamp, F., Vogt, M., Marschner, N., 2013.

Onkologie 36 (suppl. 7)(V40), 8. doi:10.1159/000356365

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGHO / Journal: Onkologie
TNK
2013
The German mRCC Registry – aims and results after the first 1000 patients.

Goebell, P.J., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Vogt, M., Marschner, N., 2013.

Eur Urol Suppl 2013;12;e1106 DOI:10.1016/S1569-9056(13)61581-X

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: EAU / Journal: -
TNK
2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis.

Fontein, D.B.Y., Seynaeve, C., Hadji, P., Hille, E.T.M., van de Water, W., Putter, H., Kranenbarg, E.M.-K., Hasenburg, A., Paridaens, R.J., Vannetzel, J.-M., Markopoulos, C., Hozumi, Y., Bartlett, J.M.S., Jones, S.E., Rea, D.W., Nortier, J.W.R., van de Velde, C.J.H., 2013.

J Clin Oncol 31, 2257–2264. doi:10.1200/JCO.2012.45.3068

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Journal of Clinical Oncology
TEAM
2013
Non-interventional study Be-1st: First line therapy with bendamustine in advanced indolent non-Hodgkin lymphoma (NHL) in treatment routine.

Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Bruch, H.-R., Straßl, L., 2013.

haematologica, EHA (Stockholm) 98, P321.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: EHA / Journal: Haematologica
Be-1st
2013
Lifestyle Faktoren – Einfluss auf die Lebensqualität beim Mammakarzinom.

Marschner, N., 2012.

J Cancer Res Clin Oncol (2012) 138(Suppl 1): 1. doi:10.1007/s00432-011-1144-4

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DKK / Journal: Journal of Cancer Research and Clinical Oncology
TMK
2012
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer.

van de Water, W., Markopoulos, C., van de Velde, C.J.H., Seynaeve, C., Hasenburg, A., Rea, D., Putter, H., Nortier, J.W.R., de Craen, A.J.M., Hille, E.T.M., Bastiaannet, E., Hadji, P., Westendorp, R.G.J., Liefers, G.-J., Jones, S.E., 2012.

JAMA 307, 590–597. doi:10.1001/jama.2012.84

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: JAMA
TEAM
2012
EGFR mutation testing in lung cancer patients of German outpatients centres – data from the clinical TLK Registry.

Tessen, H., Groschek, M., Neise, M., Schnell, R., Kopfmann, S., Hartmann, H., 2012.

Onkologie 35 (suppl 6)(P474), 139. doi:10.1159/000258182

Abstract

Download

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TLK
2012